XT
ABEO icon

XTX Topco’s Abeona Therapeutics ABEO Stock Holding History

XTX Topco’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$310K Buy
69,120
+19,782
+40% +$98.9K 0.01% 2457
2025
Q4 		$260K Buy
49,338
+9,979
+25% +$50.2K 0.01% 2194
2025
Q3 		$208K Buy
+39,359
New +$250K 0.01% 1817
2024
Q4 		– Sell
-25,301
Closed -$160K – 2220
2024
Q3 		$160K Buy
+25,301
New +$132K 0.01% 1509
2023
Q1 		– Sell
-51,888
Closed -$160K – 1223
2022
Q4 		$160K Buy
+51,888
New +$194K 0.03% 909
2021
Q3 		– Sell
-3,078
Closed -$120K – 652
2021
Q2 		$120K Buy
+3,078
New +$126K 0.04% 638

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

XTX Topco's ABEO Position: Q1 2026 in Review

XTX Topco increased its Abeona Therapeutics (ABEO) stake by 40% in Q1 2026, buying an estimated $98.9K and bringing the position to 69,120 shares worth $310K. The position accounts for 0.01% of the portfolio, ranked #2457.

XTX Topco first reported a position in ABEO in Q2 2021 and has held it in 6 quarters since. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • XTX Topco held 69,120 shares of Abeona Therapeutics worth $310K as of Q1 2026.
  • XTX Topco bought 19,782 Abeona Therapeutics shares in Q1 2026, an estimated $98.9K.
  • Abeona Therapeutics made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2457 holding.
  • XTX Topco first reported a position in Abeona Therapeutics in Q2 2021 and has held it in 6 quarters since.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.